Inventor

TALLEY JOHN J

US211 patents

⚠️ This page may combine multiple inventors who share the name “TALLEY JOHN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TALLEY JOHN J

SEARLE & CO

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted benzopyran analogs for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamides

Substituted benzopyran derivatives for the treatment of inflammation

Prodrugs of benzenesulfonamide-containing COX-2 inhibitors

Isoxazole compounds as cyclooxygenase inhibitors

1,3,5 trisubstituted pyrazole compounds for treatment of inflammation

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted benzopyran analogs for the treatment of inflammation

α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethlamino sulfonamides useful as retroviral protease inhibitors

Substituted benzopyran derivatives for the treatment of inflammation

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfanamides useful as retroviral protease inhibitors

Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies

β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Heterocyclic-substituted pyrazolyl benzenesulfonamides for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamides

Sulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitors

Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation

Method of detecting cyclooxygenase-2

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors

Process for making substituted pyrazoles

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors

Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors

(unassigned)

Substituted isoxazoles for the treatment of inflammation

Substituted pyrazolyl benzenesulfonamides for the treatment of gastrointestinal conditions

Retroviral protease inhibitors

Benzopyranopyrazolyl derivatives for the treatment of inflammation

MONSANTO CO

2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents